These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7644537)

  • 1. Gene therapy for long-term expression of erythropoietin in rats.
    Osborne WR; Ramesh N; Lau S; Clowes MM; Dale DC; Clowes AW
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8055-8. PubMed ID: 7644537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term erythropoietin gene expression from transduced cells in bioisolator devices.
    Yanay O; Barry SC; Flint LY; Brzezinski M; Barton RW; Osborne WR
    Hum Gene Ther; 2003 Nov; 14(17):1587-93. PubMed ID: 14633401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stomach implant for long-term erythropoietin expression in rats.
    Lejnieks DV; Ramesh N; Lau S; Osborne WR
    Blood; 1998 Aug; 92(3):888-93. PubMed ID: 9680356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector.
    Svensson EC; Black HB; Dugger DL; Tripathy SK; Goldwasser E; Hao Z; Chu L; Leiden JM
    Hum Gene Ther; 1997 Oct; 8(15):1797-806. PubMed ID: 9358029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D; London L; Bandach I; Segev Y
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy.
    Binley K; Askham Z; Iqball S; Spearman H; Martin L; de Alwis M; Thrasher AJ; Ali RR; Maxwell PH; Kingsman S; Naylor S
    Blood; 2002 Oct; 100(7):2406-13. PubMed ID: 12239150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.
    Naffakh N; Henri A; Villeval JL; Rouyer-Fessard P; Moullier P; Blumenfeld N; Danos O; Vainchenker W; Heard JM; Beuzard Y
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3194-8. PubMed ID: 7724539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-regulatable erythropoietin production by plasmid injection and in vivo electroporation.
    Terada Y; Tanaka H; Okado T; Shimamura H; Inoshita S; Kuwahara M; Akiba T; Sasaki S
    Kidney Int; 2002 Dec; 62(6):1966-76. PubMed ID: 12427121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.
    Ataka K; Maruyama H; Neichi T; Miyazaki J; Gejyo F
    Am J Nephrol; 2003; 23(5):315-23. PubMed ID: 12915775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.
    Sun J; Wang Y; Yang J; Du D; Li Z; Wei J; Yang A
    Exp Mol Med; 2012 Nov; 44(11):674-83. PubMed ID: 22990115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector.
    Tripathy SK; Svensson EC; Black HB; Goldwasser E; Margalith M; Hobart PM; Leiden JM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10876-80. PubMed ID: 8855275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of erythropoietin delivery from engineered muscles in mice.
    Bohl D; Heard JM
    Hum Gene Ther; 1997 Jan; 8(2):195-204. PubMed ID: 9017423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cisplatin on erythropoietin production in rats.
    Unami A; Nishina N; Terai T; Sato S; Tamura T; Noda K; Mine Y
    J Toxicol Sci; 1996 Aug; 21(3):157-65. PubMed ID: 8887884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.
    Rettinger SD; Kennedy SC; Wu X; Saylors RL; Hafenrichter DG; Flye MW; Ponder KP
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1460-4. PubMed ID: 8108431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats.
    Frede S; Fandrey J; Pagel H; Hellwig T; Jelkmann W
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R1067-71. PubMed ID: 9321887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sheep erythropoietin gene: molecular cloning and effect of hemorrhage on plasma erythropoietin and renal/liver messenger RNA in adult sheep.
    Fu P; Evans B; Lim GB; Moritz K; Wintour EM
    Mol Cell Endocrinol; 1993 Jun; 93(2):107-16. PubMed ID: 8349021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin.
    Seppen J; Barry SC; Harder B; Osborne WR
    Blood; 2001 Aug; 98(3):594-6. PubMed ID: 11468155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene.
    Oh TK; Quan GH; Kim HY; Park F; Kim ST
    Am J Nephrol; 2006; 26(4):326-34. PubMed ID: 16825758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human, rat, and mouse kidney cells express functional erythropoietin receptors.
    Westenfelder C; Biddle DL; Baranowski RL
    Kidney Int; 1999 Mar; 55(3):808-20. PubMed ID: 10027918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.